Share
my son Rudranil who is just completed his 7th birthday recently again diagnosed with Acute Lymphoblastic Leukemia (ALL) with second time relapse.
ALL is one type of Blood Cancer, and he is fighting with it since 2017, despite our best efforts and treatments in India.
Recently around 3 months back he started developing acute symptoms and again diagnosed a relapse. Consulting doctor told us chemotherapy with radiations are self-limiting for him at this stage of cancer and advised us to prepare for CAR T- Cell therapy.
(In short, about CAR T- Cell therapy: Chimeric antigen receptor (CAR) T-cell therapy a type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient’s blood. Then the gene for a special receptor that binds to a certain protein on the patient’s cancer cells, added to the T cells in the laboratory. The special receptor, called a chimeric antigen receptor (CAR). Large numbers of the CAR T cells are grown in the lab and given to the patient by infusion.)
This treatment has the best chance for my son’s survival at this point of time but highly expensive in nature. Currently not available in India. We have to visit the nearest medical facilities at Singapore or Israel to perform this treatment. This treatment will cost us a minimum of USD 126,000 – 153,000 approximately.
We do not have any arrangement to generate this much of humongous fund, hence looking for crowd funding option.
We are short of fund at the moment and requesting your kind support and guidance, for my son’s future treatment and survival please.
Regards,
Indranil Das
ALL is one type of Blood Cancer, and he is fighting with it since 2017, despite our best efforts and treatments in India.
Recently around 3 months back he started developing acute symptoms and again diagnosed a relapse. Consulting doctor told us chemotherapy with radiations are self-limiting for him at this stage of cancer and advised us to prepare for CAR T- Cell therapy.
(In short, about CAR T- Cell therapy: Chimeric antigen receptor (CAR) T-cell therapy a type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient’s blood. Then the gene for a special receptor that binds to a certain protein on the patient’s cancer cells, added to the T cells in the laboratory. The special receptor, called a chimeric antigen receptor (CAR). Large numbers of the CAR T cells are grown in the lab and given to the patient by infusion.)
This treatment has the best chance for my son’s survival at this point of time but highly expensive in nature. Currently not available in India. We have to visit the nearest medical facilities at Singapore or Israel to perform this treatment. This treatment will cost us a minimum of USD 126,000 – 153,000 approximately.
We do not have any arrangement to generate this much of humongous fund, hence looking for crowd funding option.
We are short of fund at the moment and requesting your kind support and guidance, for my son’s future treatment and survival please.
Regards,
Indranil Das
